RPT-EMA: EMA STARTED A ROLLING REVIEW FOR VERSION OF COMIRNATY ADAPTED TO ORIGINAL SARS-COV-2 VIRUS AND TO ITS OMICRON SUBVARIANTS BA.4/5: 09/08/2022